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Abstract
Nausea and vomiting following anaesthesia is a distressing problem for patients as it increases recovery time, the intensity of
nursing care and delays discharge. The aim of the randomized control single blind study is to evaluate the efficacy and safety of
subhypnotic dose of propofol for prevention of postoperative nausea and vomiting (PONV) in gynecological surgeries. 40
females (ASAI) scheduled for either vaginal or abdominal hysterectomies under sub arachnoid block were randomly given either
Propofol 20mg i.v / Group P (n=20) or Normal Saline 2ml i.v / Group C (n=20) at the end of surgery. A person who was blinded
to the study evaluated them for PONV for 24 hrs.
The study found that the incidence of nausea was reduced in the propofol group (Group P) and was statistically significant
(P<0.05) in the 4th -- 24th hour postoperative period. The incidence of vomiting was also significantly reduced (P<0.05) in the
propofol group there was 65% incidence of vomiting in the control group when compared to 25% incidence of vomiting in the
propofol group. No hemodynamic derangements were noted in the post operative period..
In conclusion, a subhypnotic dose of propofol is an effective antiemetic for gynaecological surgeries.
INTRODUCTION
The first extensive description of post operative nausea and
vomiting (PONV) was made by John Snow in 1845 within 2
yrs of demonstration of ether anaesthesia by WTG Morton.
Although much effort rightly has been placed on providing
adequate pain relief after surgery, many physicians continue
to view PONV as a minor complication that poses a little
problem to the patient. In contrast many patients view
PONV as more debilitating than the surgery itself. This
complication is not only unpleasant and aesthetically
displeasing to patients and their care givers but when severe,
is associated with wound dehiscence, bleeding electrolyte
imbalance, dehydration and rarely pulmonary aspiration of
gastric contents. Yet this complication has been called as the
“big little, problem”.
Major gynecological surgeries are associated with the
highest incidence of PONV- as high as 60-83% of patients
experiencing the emetic sequelae. Propofol is an disopropyl
phenol derivative used for induction and maintenance of
surgeries. Propofol has been known to exert antimetic
properties even in sub-hypnotic doses and hence we decided
to checkout this claim.
MATERIALS AND METHODS
A) STUDY DESIGN
After approval of the ethics committee, 40 female patients
undergoing vaginal or total abdominal hysterectomy were
randomly assigned into two groups
Group P – Given Inj. Propofol 20mg i.v at the end of surgery
Group C – Control group given Inj. Normal saline 2mli.v at
the end of surgery.
All patients were evaluated in the preanaesthetic clinic for
a) History of allergy
b) Systemic disorders
c) History of vomiting disorders
B) SELECTION CRITERIA:
a) ASA I & II
b) No history of vomiting disorders – or drug allergy.
C) METHOD:
All patients were premedicated with Tab. Diazepam 5mg in
the night and on the morning of surgery and with Inj.
Pentazocine 30mg 1/m 45 minutes prior to surgery. Patients
were transported to the theatre where an intravenous lifeline
was started with 18G i.v cannula. Baseline pulse rate and
Efficacy Of Propofol In Preventing Postoperative Nausea And Vomiting (PONV): Single Blind Randomized
Control Study
2 of 3
blood pressure were measured. All patients were preloaded
with 500ml ringers lactate solution.
With all aseptic precautions and patients in the lateral
position, 4ml of 0.5% Bupivacaine (heavy) was injected
intrathecally at the L3-4 or L2-3 space with a 23G spinal
Quincke needle. All patients were monitored through the
surgery period with pulse oximeter, NIBP and ECG
monitors. Hypotension was defined as a fall of BP by 30%
from the baseline. At the end of the surgery the patients
received Inj. Propofol or normal saline randomly.
All patients were evaluated for hemodynamic derangements,
nausea and vomiting for the 1st hour in the post operative
room and thereafter in the post operative ward for 24 hrs by
a person who was blinded to the study. Nausea was defined
as a subjective, unpleasant sensation in the epigastrium and
the throat with the urge to vomit.
Vomiting was defined as the forceful expulsion of gastric
contents from the mouth.
Retching was defined as the labored contraction of
diaphragm and abdominal muscles with no expulsion of
gastric contents.
Inj. Metaclopramide 5mg i.v was given as a rescue
antiemetic if more than 3 emetic episodes prevailed.
D) STATISTICS:
Demographic profile – unpaired students ‘t' test.
Nausea & vomiting – Chi-Square test.
RESULTS
Both groups were comparable with respect to age and
weight. The demographic data is given in Table 1.
Figure 1
Table 1: Demographic profile
There was reduction in the incidence of nausea in the
propofol group when compared to the control group and a
higher percentage of patients were free of nausea after 4hrs
post operatively (P<0.05). Graph 1
Figure 2
Graph 1
The overall incidence of vomiting in the first 24hrs
postoperatively was significantly less in the propofol group
(25%) as compared to the control group (65%) [P<0.05].
Graph 2. The relative number of emetic episodes and the
need for rescue antiemetic therapy was also reduced. Rescue
antiemetics were given to 55% of the patients in the control
group while none in the propofol group required the same.
Figure 3
Graph 2
DISCUSSION
Vomiting is a complex integrated reflex act with three major
components
a) emetic detectors
b) integrative centers
c) motor outputs.
Emetic detectors include the chemo and mechanoceptors of
the GIT, the chemorecptor trigger zone, and the vestibular
apparatus. The integrative centres lie in the Botzinger
complex, situated in the dorsolateral reticular formation of
the brainstem. The vomiting center is predominant in
serotoninergic (5-HT3), dopaminergic (D2) and muscarinic
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(M3) receptors. The Nucleus Tracus Solatarins (NTS) is the
main receptor site which integrates information to the dorsal
vagal nucleus for parasympathetic responses; nucleus
ambigus for glottic closure and to the reticular formation and
spinal cord for contraction of diaphragm and abdominal
muscles.
The act of vomiting has 3 phases.
a) Preejection phase characterized by prodromal symptoms
like sweating, salivation, swallowing, relaxation of proximal
stomach with retrograde contraction of stomach
b) ejection phase characterized by retching and vomiting of
gastric contents through by mouth
c) post ejection phase characterized by fluid and electrolyte
imbalance,lethargy and muscular weakness
The etiology of PONV is multifactorial. It is more common
in the pediatric age group especially between 11-14 yrs.It is
prevalent more in adult females and obese individuals.
Abdominal surgeries , adenotonsillectomies ,middle ear
surgeries ,eye surgeries and gynecological surgeries have
increased PONV. Stimulation of the uterus, broad ligament,
vagina and cervix causes vomiting through afferents to the
spinal cord along the hypogastric and pelvic plexuses.
PONV is common in surgeries where the vagina is packed or
the cervix is dilated. PONV usually lasts for less than 24 hrs
and is usually more intense during the first 2 hours. In
general vomiting and retching subside before nausea.
Surgical pain increases the circulating catecholamines which
causes PONV by stimulating area postrema.
Management of PONV ranges from pharmacological therapy
using an array of antiemetics to non pharmacological
methods of acupuncture at P6 or Neiguen point and
hypnosis.Even though a battery of powerful antiemetics are
available, the use of propofol,an intravenous anaesthetic
agent, for preventing nausea and vomiting is a newer
concept.Infact it is ironical that of all the intravenous agents
available propofol alone is associated with little nausea and
vomiting.
The mechanism of propofol induced anti emesis is quite
unclear. The antiemetic properties have been explained by
its possible action on the vomiting centre and the CTZ.
Propofol has a profile of central nervous system depression
that differs from other anesthetic drugs. In contrast to
thiopental, propofol uniformly depresses the CNS including
the subcortical centres where most of the antiemetics act.
Hence modulation of the subcortical structures could be a
possible mechanism of propofol antiemesis. It is remarkable
that propofol was used as an antiemetic in patients receiving
cisplatin therapy. Studies have shown that in subhypnotic
doses of 10 mg iv bolus, propofol eliminates postoperative
nausea. The median plasma concentration of propofol
associated with an antiemetic property was 343 ng/ml. The
concentration can be achieved by propofol infusion of 10-20
mcg/kg /min. Propofol given at the end of surgery as a bolus
has been widely proclaimed as the sandwich technique and
this has been shown to reduce the PONV incidence .
The clincal implication of the study is manifold. Firstly the
efficacy of subhypnotic dose of propofol in reducing the
PONV incidence was proved. Secondly the antiemetic
properties of propofol can be made use of in day care
surgeries and in monitored amaesthesia care where PONV
can be distressing. It can also be used for surgeries which
have increased PONV (gynecological, adenotonsillectomies,
laparoscopies etc) for induction and maintenance of
anesthesia since propofol reduces PONV more than other
inhalation and intravenous agents.
CONCLUSION
In conclusion this study has shown that propofol in
subhypnotic doses possesses antiemetic properties. It is
effective in reducing nausea in the 4-24 hr period
postoperatively and significantly reduces the incidence of
vomiting with minimal side effects. The number of emetic
episodes and the rescue antiemetic therapy is grossly
reduced even though the mechanism of its antiemetic action
remains to be deciphered.
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